Enanta Pharmaceuticals, Inc. - Common Stock (ENTA)

Enanta Pharmaceuticals is a biotechnology company focused on discovering and developing innovative therapies for infectious diseases and liver diseases

The company specializes in the research and development of small molecule drugs, primarily targeting viral infections such as hepatitis B and hepatitis C, as well as other serious medical conditions. Enanta collaborates with pharmaceutical partners to advance its pipeline of novel antiviral therapeutics, aiming to address unmet medical needs and improve patient outcomes through its scientific expertise and commitment to drug development.